EUREPA

Main information

  • Trade name:
  • EUREPA 10 TAB
  • Dosage:
  • 1MG
  • Pharmaceutical form:
  • TAB
  • Composition:
  • 10
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • EUREPA 10 TAB
    India
  • Language:
  • English

Other information

Status

  • Source:
  • Central Drugs Standard Control Organization
  • Last update:
  • 09-08-2016

13-4-2018

REPAGLINIDE Tablet [Rising Health, LLC]

REPAGLINIDE Tablet [Rising Health, LLC]

Updated Date: Apr 13, 2018 EST

US - DailyMed

22-2-2018

REPAGLINIDE Tablet [Sandoz Inc]

REPAGLINIDE Tablet [Sandoz Inc]

Updated Date: Feb 22, 2018 EST

US - DailyMed

28-12-2017

PRANDIN (Repaglinide) Tablet [Carilion Materials Management]

PRANDIN (Repaglinide) Tablet [Carilion Materials Management]

Updated Date: Dec 28, 2017 EST

US - DailyMed

20-12-2017

PRANDIN (Repaglinide) Tablet [Gemini Laboratories, LLC]

PRANDIN (Repaglinide) Tablet [Gemini Laboratories, LLC]

Updated Date: Dec 20, 2017 EST

US - DailyMed

7-11-2017

REPAGLINIDE Tablet [American Health Packaging]

REPAGLINIDE Tablet [American Health Packaging]

Updated Date: Nov 7, 2017 EST

US - DailyMed

31-10-2017

REPAGLINIDE Tablet [Mylan Institutional Inc.]

REPAGLINIDE Tablet [Mylan Institutional Inc.]

Updated Date: Oct 31, 2017 EST

US - DailyMed

2-8-2017

REPAGLINIDE Tablet [Paddock Laboratories, LLC]

REPAGLINIDE Tablet [Paddock Laboratories, LLC]

Updated Date: Aug 2, 2017 EST

US - DailyMed

20-6-2017

REPAGLINIDE AND METFORMIN HYDROCHLORIDE Tablet [Lupin Pharmaceuticals, Inc.]

REPAGLINIDE AND METFORMIN HYDROCHLORIDE Tablet [Lupin Pharmaceuticals, Inc.]

Updated Date: Jun 20, 2017 EST

US - DailyMed

3-5-2017

Prandin (Novo Nordisk A/S)

Prandin (Novo Nordisk A/S)

Prandin (Active substance: Repaglinide) - Centralised - Yearly update - Commission Decision (2017)2969 of Wed, 03 May 2017

Europe -DG Health and Food Safety

3-5-2017

NovoNorm (Novo Nordisk A/S)

NovoNorm (Novo Nordisk A/S)

NovoNorm (Active substance: Repaglinide) - Centralised - Yearly update - Commission Decision (2017)2985 of Wed, 03 May 2017

Europe -DG Health and Food Safety

3-5-2017

Repaglinide Teva (Teva B.V.)

Repaglinide Teva (Teva B.V.)

Repaglinide Teva (Active substance: Repaglinide) - Centralised - Yearly update - Commission Decision (2017)2983 of Wed, 03 May 2017

Europe -DG Health and Food Safety